Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome.
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Fluvastatin (Primary)
- Indications Metabolic syndrome
- Focus Therapeutic Use
- Sponsors Novartis
- 07 Nov 2011 Actual end date (February 2006) added as reported by ClinicalTrials.gov.
- 13 Dec 2008 New trial record.